Login

Dr. Vishal Swaminathan - Residency at Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Residents describe their training experience at Mayo Clinic's Department of Ophthalmology.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Understand the circuitry of the mammalian cerebral cortex / Richard Born, MD Professor of Neurobiology, HMS
00:10:00
Jerry Shelton & Mark Sawicki of Cryoport: Keynote at Advanced Therapies Congress 2019 | Jerry Shelton - CEO of Cryoport, Inc.
00:00:00
William C. Palmer, M.D. Gastroenterologist, Mayo Clinic
00:10:00
Sunshine Metals Sees More Precious and Base Metal Bounty at Liontown Project | Dr. Damien Keys, Managing Director, Sunshine Metals Ltd.
00:10:00
Empowering a Zero-Carbon Future | Will Gardiner, CEO, Drax Group PLC.
00:10:00
CapMan's Strategic Updates and Ambitious Growth Targets Discussed by CEO Joakim Frimodig | Joakim Frimodig, CEO, CapMan.
00:10:00
Fostering Societal Contribution Beyond Profit: A Call for Wildlife Conservation |Harald Link, CEO, B Grimm Power PCL.
00:10:00
"High Yield Bond Market Outlook for the Second Half of 2024: Key Insights from AXA’s Fund Manager and BBLAM's Navarat Jeamkijrung"
00:10:00
Pioneering Immune Medicine and Driving Collaborative Health Tech Solutions. |Chad Robbin , CEO, Adaptive Biotechnologies.
00:10:00
Why "Bespoke": Custom-Tailored Portfolios with Laurel Hardy | Laurel Hardy, CEO, Bespoke Wealth Management.
00:10:00
Partnering for Success: Mazzone & Associates and Cherry Bekaert's Collaborative Approach
00:10:00
From Wall Street to Wealth Planning: Sam Brown's Journey from Investment Banking to Financial Advisory

© 2026 Nehu